References
- Squires J.E. Artificial blood. Science 2002; 295: 1002–1005, Review
- Chang T.M.S. Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem. Biophys. Res. Commun. 1971; 44(6)1531–1536
- Lanzkron S., Moliterno A.R., Norris E.J., et al. Polymerized human Hb use in acute chest syndrome: a case report. Transfusion 2002; 42: 1422–1427
- Chang T.M.S. Future generations of red blood cell substitutes. J. Intern. Med. 2003; 253: 527–535
- Winslow R.M. Current status of blood substitute research: towards a new paradigm. J. Intern. Med. 2003; 253: 508–517
- Moore E.E., Johnson J.L., Cheng A.M., et al. Insights from studies of blood substitutes in trauma. Shock 2005; 24: 197–205
- MacDonald S.L, Pepper D.S. Hemoglobin polymerization. Methods Enzymol. 1994; 231: 287–308
- Eike J.H., Palmer A.F. Effect of glutaraldehyde concentration on the physical properties of polymerized hemoglobin-based oxygen carriers. Biotechnol. Prog. 2004; 20: 1225–1232
- Eike H.E., Palmer A.F. Effect of NaBH4 concentration and reaction time on physical properties of glutaraldehyde-polymerized hemoglobin. Biotechnol. Prog. 2004; 20: 946–952
- Tao, Hu and Zhiguo, Su. 2003. C.N. Patent 01136190.5.